Tong M, Saito T, Zhai P, Oka SI, Mizushima W, Nakamura M, Ikeda S, Shirakabe A, Sadoshima J. Mitophagy is essential for maintaining cardiac function during high fat diet-induced diabetic cardiomyopathy. Circ Res. 2019;124(9):1360–71. https://doi.org/10.1161/CIRCRESAHA.118.314607.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li H, Zhu X, Cao X, Lu Y, Zhou J, Zhang X. Single-cell analysis reveals lysyl oxidase (Lox)+ fibroblast subset involved in cardiac fibrosis of diabetic mice. J Adv Res. 2023;54:223–37. https://doi.org/10.1016/j.jare.2023.01.018.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pappritz K, Grune J, Klein O, Hegemann N, Dong F. Speckle-tracking echocardiography combined with imaging mass spectrometry assesses region-dependent alterations. Sci Rep. 2020;10(1):3629. https://doi.org/10.1038/s41598-020-60594-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Haas AV, McDonnell ME. Pathogenesis of cardiovascular disease in diabetes. Endocrinol Metab Clin N Am. 2018;47(1):51–63. https://doi.org/10.1016/j.ecl.2017.10.010.

Article  Google Scholar 

Jensen MT, Fung K, Aung N, Sanghvi MM. Changes in cardiac morphology and function in individuals with diabetes mellitus: the UK biobank cardiovascular magnetic resonance substudy. Circ Cardiovasc Imaging. 2019;12(9): e009476. https://doi.org/10.1161/CIRCIMAGING.119.009476.

Article  PubMed  PubMed Central  Google Scholar 

Chen R, Zhang H, Tang B, Luo Y, Yang Y, Zhong X, Chen S, Xu X. Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets. Signal Transduct Target Ther. 2024;9(1):130. https://doi.org/10.1038/s41392-024-01840-1.

Article  PubMed  PubMed Central  Google Scholar 

Shu S, Cui H, Liu Z, Zhang H, Yang Y, Chen X. Suppression of RCAN1 alleviated lipid accumulation and mitochondrial fission in diabetic cardiomyopathy. Metabolism. 2024;158: 155977. https://doi.org/10.1016/j.metabol.2024.155977.

Article  CAS  PubMed  Google Scholar 

Ritchie RH, Abel ED. Basic mechanisms of diabetic heart disease. Circ Res. 2020;126(11):1501–25. https://doi.org/10.1161/CIRCRESAHA.120.315913.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou Y, Suo W, Zhang X, Yang Y, Zhao W, Li H, Ni Q. Targeting epigenetics in diabetic cardiomyopathy: therapeutic potential of flavonoids. Biomed Pharmacother. 2023;157: 114025. https://doi.org/10.1016/j.biopha.2022.114025.

Article  CAS  PubMed  Google Scholar 

Ling C, Rönn T. Epigenetics in human obesity and type 2 diabetes. Cell Metab. 2019;29(5):1028–44. https://doi.org/10.1016/j.cmet.2019.03.009.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee JM, Hammarén HM, Savitski MM, Baek SH. Control of protein stability by post-translational modifications. Nat Commun. 2023;14(1):201. https://doi.org/10.1038/s41467-023-35795-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jazieh C, Arabi TZ, Asim Z, Sabbah BN, Alsaud AW, Alkattan K, Yaqinuddin A. Unraveling the epigenetic fabric of type 2 diabetes mellitus: pathogenic mechanisms and therapeutic implications. Front Endocrinol (Lausanne). 2024;15:1295967. https://doi.org/10.3389/fendo.2024.1295967.

Article  PubMed  PubMed Central  Google Scholar 

Li Z, Chen J, Huang H, Zhan Q, Wang F, Chen Z, Lu X, Sun G. Post-translational modifications in diabetic cardiomyopathy. J Cell Mol Med. 2024;28(7): e18158. https://doi.org/10.1111/jcmm.18158.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li X, Yang Y, Zhang B, Lin X, Fu X. Lactate metabolism in human health and disease. Signal Transduct Target Ther. 2022;7(1):305. https://doi.org/10.1038/s41392-022-01151-3. Erratum in: Signal Transduct Target Ther. 2022;7(1):372. https://doi.org/10.1038/s41392-022-01206-5.

Zhou T, Cheng X, He Y, Xie Y, Xu F, Xu Y, Huang W. Function and mechanism of histone β-hydroxybutyrylation in health and disease. Front Immunol. 2022;13: 981285. https://doi.org/10.3389/fimmu.2022.981285.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gut P, Matilainen S, Meyer JG, Pällijeff P, Richard J, Carroll CJ, Euro L. SUCLA2 mutations cause global protein succinylation contributing to the pathomechanism of a hereditary mitochondrial disease. Nat Commun. 2020;11(1):5927. https://doi.org/10.1038/s41467-020-19743-4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng X, Wang K, Zhao Y, Wang K. Research progress on post-translational modification of proteins and cardiovascular diseases. Cell Death Discov. 2023;9(1):275. https://doi.org/10.1038/s41420-023-01560-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bornstein MR, Tian R, Arany Z. Human cardiac metabolism. Cell Metab. 2024;36(7):1456–81. https://doi.org/10.1016/j.cmet.2024.06.003.

Article  CAS  PubMed  Google Scholar 

Da Dalt L, Cabodevilla AG, Goldberg IJ, Norata GD. Cardiac lipid metabolism, mitochondrial function, and heart failure. Cardiovasc Res. 2023;119(10):1905–14. https://doi.org/10.1093/cvr/cvad100.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kazmi DH, Kapoor A, Sinha A. Role of metabolic manipulator trimetazidine in limiting percutaneous coronary intervention-induced myocardial injury. Indian Heart J. 2018;70(Suppl 3):S365–71. https://doi.org/10.1016/j.ihj.2018.10.415.

Article  PubMed  PubMed Central  Google Scholar 

Heather LC, Gopal K, Srnic N, Ussher JR. Redefining diabetic cardiomyopathy: perturbations in substrate metabolism at the heart of its pathology. Diabetes. 2024;73(5):659–70. https://doi.org/10.2337/dbi23-0019.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kota SK, Kota SK, Jammula S, Panda S, Modi KD. Effect of diabetes on alteration of metabolism in cardiac myocytes: therapeutic implications. Diabetes Technol Ther. 2011;13(11):1155–60. https://doi.org/10.1089/dia.2011.0120.

Article  CAS  PubMed  Google Scholar 

Rider OJ, Apps A, Miller JJJJ, Lau JYC, Lewis AJM. Noninvasive in vivo assessment of cardiac metabolism in the healthy and diabetic human heart using hyperpolarized 13C MRI. Circ Res. 2020;126(6):725–36. https://doi.org/10.1161/CIRCRESAHA.119.316260.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ju J, Xiao D, Shen N, Zhou T, Che H, Li X, Zhang S, Mokembo JN, Jha NK, Monayo SM, Wang Z, Zhang Y. miR-150 regulates glucose utilization through targeting GLUT4 in insulin-resistant cardiomyocytes. Acta Biochim Biophys Sin (Shanghai). 2020;52(10):1111–9. https://doi.org/10.1093/abbs/gmaa094.

Article  CAS  PubMed  Google Scholar 

Mansor LS, Sousa Fialho MDL, Yea G, Coumans WA. Inhibition of sarcolemmal FAT/CD36 by sulfo-N-succinimidyl oleate rapidly corrects metabolism and restores function in the diabetic heart following hypoxia/reoxygenation. Cardiovasc Res. 2017;113(7):737–48. https://doi.org/10.1093/cvr/cvx045.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Montaigne D, Butruille L, Staels B. PPAR control of metabolism and cardiovascular functions. Nat Rev Cardiol. 2021;18(12):809–23. https://doi.org/10.1038/s41569-021-00569-6.

Article  CAS  PubMed  Google Scholar 

Finck BN, Lehman JJ, Leone TC, Welch MJ, Bennett MJ. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus